about
Pharmacokinetic drug interactions in liver disease: An updateAn NBD Derivative of the Selective Rat Toxicant Norbormide as a New Probe for Living Cell ImagingExpression and distribution of the adrenomedullin system in newborn human thymus.The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASHEnzyme inhibition and induction in liver disease.The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat.Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice.Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells.Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders.The ecto-enzymes CD73 and adenosine deaminase modulate 5'-AMP-derived adenosine in myofibroblasts of the rat small intestineDexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activationExtrahepatic autoimmunity in autoimmune liver diseaseEtiopathogenesis of autoimmune hepatitisCo-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipientsLiver dysfunction markedly decreases the inhibition of cytochrome P450 1A2–mediated theophylline metabolism by fluvoxamineLive applications of norbormide-based fluorescent probes in Drosophila melanogasterThe Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer CellsWestern Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of SteatosisDopamine-mediated immunomodulation affects choroid plexus functionFucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in RatsNemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells
P50
Q26774479-9169F29D-2D4A-48A0-93D8-7C0171B2383FQ27308015-881383AF-9E80-4F47-B9A9-745D4338981CQ35169380-211F7960-178E-433E-BF5E-FDCDC1FBE186Q36284003-D0B823CA-BB85-41BE-A2F6-8E3FC451AB31Q37239212-366E1190-0488-490A-BC05-F37EB402AADFQ37770251-803D17B9-772F-4B01-AE45-F45BD048D921Q39317953-9997AC62-B9CA-4BAB-AD6E-E4F46A4CA911Q41088828-55C6C0B1-4A96-4F68-9B17-B8B8DE13F345Q42462217-81193184-3CD2-4D0E-B24F-8A41D819B780Q44746778-54B3D0C0-C5AE-4EC2-B102-64FB1C805990Q46237124-DE1FE500-ED21-47B1-8B69-EE9D61FFE502Q46451386-8DF7FE0B-2EF3-4332-ABFA-17848D426804Q48325676-AFA009BF-E902-42DD-A822-C5604AE96984Q48635526-43D9BF1E-5351-4BE6-AEE1-2B4FF71752CCQ51516706-C51BB3B2-DC70-4C18-90DA-40647D7ABC5EQ52686765-7B0261E2-02E8-4087-A453-A7CE4B8FF1A8Q57098246-87017EF0-E2F6-4FB4-B25C-5420CA83B0D6Q57107773-441056E5-0D39-45E0-AD63-99E282E61D3FQ58580059-ED1343B4-2DC9-4384-883B-5AE3C7A10DF9Q60193422-1AEF094E-29F5-40DA-86FF-E3E73033F1E5Q61388025-D97658C4-A073-46D3-B340-934DE27A2A3CQ61388026-4748CCF2-6914-44DF-A41E-78441E75297AQ64068143-29BE4BBD-8F53-474A-9610-2A9E60CB115BQ90190038-42CCD1BE-0A9C-4D92-AC08-FCCF96177800Q91928199-E57B6290-3017-40D9-BE51-FB2DF22C265BQ92600768-0319D473-E3A2-48D1-8A41-8CCD71DC1823Q92812583-8665B610-1CD6-4573-9A17-657BE16F434EQ93055804-438B1F91-38F2-46CC-A2F7-88844C39E73E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara De Martin
@ast
Sara De Martin
@en
Sara De Martin
@es
Sara De Martin
@nl
Sara De Martin
@sl
type
label
Sara De Martin
@ast
Sara De Martin
@en
Sara De Martin
@es
Sara De Martin
@nl
Sara De Martin
@sl
prefLabel
Sara De Martin
@ast
Sara De Martin
@en
Sara De Martin
@es
Sara De Martin
@nl
Sara De Martin
@sl
P106
P1153
7801626699
P21
P31
P496
0000-0001-6398-8237